
| 2 min read
The next-generation tool, called Partita, identified both known and novel genes that contribute to resistance in lymphomas.
| 2 min read
New findings slowed tumor growth in a mouse model of triple-negative breast cancer, offering a new template for RNA drug design.
| 4 min read
A win for autoimmune disease, a set back for Alzheimer’s disease, an FDA backing for a multi-cancer blood test, and more led the news this week.
| 3 min read
Autonomous agents flagged a family of phage enzymes with CRISPR-like repeats, though what the system does remains unknown.News
Cancer Research News
Final PAPILLON data show amivantamab-vmjw plus chemotherapy reaches 34 months median OS, the longest reported in this historically treatment-resistant NSCLC subtype
CAR T has transformed treatment for some blood cancers, but manufacturing and healthcare system constraints still prevent many eligible patients from receiving it.
Editor's Pick
Born to differentiate and heal, mesenchymal stem cells carry great potential for treating a wide spectrum of diseases.
In a journey fraught with heartache and persistence, medical research giants paved the way for successful bone marrow transplantation.
Multimedia
Explore how advances in liquid handling are making automation more accessible, flexible, and practical for modern labs.
Explore how integrated cell-based assays reveal the mechanisms that drive antibody-drug conjugate activity and inform candidate selection.




















